CLNN - Financial Reports List - Clene Inc. - IntrinsicAlpha

Clene Inc. CLNN

Healthcare - Biotechnology - NASDAQ - US

$ 2.48

-3.85 %

$ 22.3 M

Market Cap

-0.62

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	10.96%	93.22%	55.85%
Quarterly Report	Q4	8-K	2024-12-31	-46.47%	-33.19%	12.84%
Annual Report	FY	10-K	2024-12-31	-47.71%	20.41%	18.37%
Quarterly Report	Q3	8-K	2024-09-30	-19.44%	-230.27%	18.10%
Quarterly Report	Q2	8-K	2024-06-30	-66.17%	73.01%	28.49%
Quarterly Report	Q1	8-K	2024-03-31	-31.78%	20.14%	9.12%
Quarterly Report	Q4	8-K	2023-12-31	-27.35%	-118.08%	7.40%
Annual Report	FY	10-K	2023-12-31	38.27%	-224.00%	10.57%
Quarterly Report	Q3	8-K	2023-09-30	-37.93%	80.06%	-15.77%
Quarterly Report	Q2	8-K	2023-06-30	668.57%	-454.54%	23.97%

1